3 transcripts
ABT
Earnings call transcript
NYSE
2024 Q2
18 Jul 24
our trend of capturing market share in the global TAVR market.
In Rhythm Management, growth of 6% was led by Aveir, our highly innovative leadless
ABT
Earnings call transcript
NYSE
2024 Q1
17 Apr 24
in ablation catheters and cardiac mapping related products. We continue to make great progress towards bringing our innovative PFA catheter Volt
ABT
Earnings call transcript
NYSE
2023 Q2
20 Jul 23
half of this year, we introduced several new innovations, including the launch of Eterna, and label indication expansions for treating painful
- Prev
- 1
- Next